UM  > 中華醫藥研究院
Is the United States still dominant in the global pharmaceutical innovation network?
Hu Y.1; Scherngell T.2; Man S.N.1; Wang Y.1
2013
Source PublicationPLoS ONE
ISSN19326203
Volume8Issue:11
Abstract

The dramatic growth of research and development activities in the pharmaceutical sector in emerging economies raises the question of whether the United States still keeps its dominant role in the global pharmaceutical innovation landscape. This paper focuses on investigating the role of the United States in global pharmaceutical innovation, and differs from previous studies by shifting attention to a network analytic perspective to track the global distribution of pharmaceutical inventions. Our sample is composed of key patents covering all new drugs approved by the Food and Drug Administration between 1996 and 2010. The results show that the United States still dominates in the global pharmaceutical innovation network, especially when it comes to essential core inventions. However, the United States shows a slightly decreasing prominence in the networks of either total new drugs or New Molecular Entity (NME) drugs in the time period 2006-2010 as compared to previous time periods, revealed by subtle traces of network centralities. © 2013 Hu et al.

DOIhttp://doi.org/10.1371/journal.pone.0077247
URLView the original
Indexed BySCI
Language英语
WOS Research AreaScience & Technology - Other Topics
WOS SubjectMultidisciplinary Sciences
WOS IDWOS:000326597400006
The Source to ArticleScopus
Fulltext Access
Citation statistics
Cited Times [WOS]:13   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorHu Y.; Wang Y.
Affiliation1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China
2.Foresight & Policy Development Department, AIT Austrian Institute of Technology, Vienna, Austria
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Hu Y.,Scherngell T.,Man S.N.,et al. Is the United States still dominant in the global pharmaceutical innovation network?[J]. PLoS ONE,2013,8(11).
APA Hu Y.,Scherngell T.,Man S.N.,&Wang Y..(2013).Is the United States still dominant in the global pharmaceutical innovation network?.PLoS ONE,8(11).
MLA Hu Y.,et al."Is the United States still dominant in the global pharmaceutical innovation network?".PLoS ONE 8.11(2013).
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Hu Y.]'s Articles
[Scherngell T.]'s Articles
[Man S.N.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hu Y.]'s Articles
[Scherngell T.]'s Articles
[Man S.N.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hu Y.]'s Articles
[Scherngell T.]'s Articles
[Man S.N.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.